User profiles for Eric Fauman
Eric FaumanExecutive Director,Integrative Biology, Internal Medicine Research Unit, Pfizer Worldwide Verified email at pfizer.com Cited by 9097 |
An atlas of genetic influences on human blood metabolites
Genome-wide association scans with high-throughput metabolic profiling provide unprecedented
insights into how genetic variation influences metabolism and complex disease. Here …
insights into how genetic variation influences metabolism and complex disease. Here …
Pharmacology and mechanism of action of pregabalin: the calcium channel α2–δ (alpha2–delta) subunit as a target for antiepileptic drug discovery
CP Taylor, T Angelotti, E Fauman - Epilepsy research, 2007 - Elsevier
Pregabalin (Lyrica™) is a new antiepileptic drug that is active in animal seizure models.
Pregabalin is approved in US and Europe for adjunctive therapy of partial seizures in adults, …
Pregabalin is approved in US and Europe for adjunctive therapy of partial seizures in adults, …
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
…, F De Masi, S Elmståhl, G Engström, E Fauman… - Nature …, 2020 - nature.com
Circulating proteins are vital in human health and disease and are frequently used as
biomarkers for clinical decision-making or as targets for pharmacological intervention. Here, we …
biomarkers for clinical decision-making or as targets for pharmacological intervention. Here, we …
An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci
Genome-wide association studies (GWASs) have identified many variants associated with
complex traits, but identifying the causal gene(s) is a major challenge. In the present study, we …
complex traits, but identifying the causal gene(s) is a major challenge. In the present study, we …
[HTML][HTML] Plasma proteomic associations with genetics and health in the UK Biobank
The Pharma Proteomics Project is a precompetitive biopharmaceutical consortium characterizing
the plasma proteomic profiles of 54,219 UK Biobank participants. Here we provide a …
the plasma proteomic profiles of 54,219 UK Biobank participants. Here we provide a …
Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach
Using a nontargeted metabolomics approach of 447 fasting plasma metabolites, we searched
for novel molecular markers that arise before and after hyperglycemia in a large population…
for novel molecular markers that arise before and after hyperglycemia in a large population…
Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate
PROTEIN tyrosine phosphatases (PTPases) and kinases coregulate the critical levels of
phosphorylation necessary for intracellular signalling, cell growth and differentiation 1,2 . …
phosphorylation necessary for intracellular signalling, cell growth and differentiation 1,2 . …
[HTML][HTML] Rare and common genetic determinants of metabolic individuality and their effects on human health
Garrod’s concept of ‘chemical individuality’ has contributed to comprehension of the
molecular origins of human diseases. Untargeted high-throughput metabolomic technologies …
molecular origins of human diseases. Untargeted high-throughput metabolomic technologies …
Structure and function of theprotein tyrosine phosphatases
The tyrosine and dual-specificity phosphatases are involved in signaling,cell growth and
differentiation, and the cell cycle. The enzymes share a common catalytic mechanism mediated …
differentiation, and the cell cycle. The enzymes share a common catalytic mechanism mediated …
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms
Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide 1 , 2
. Although 58 genomic regions have been associated with CAD thus far 3 , 4 , 5 , 6 , 7 , 8 , 9 , …
. Although 58 genomic regions have been associated with CAD thus far 3 , 4 , 5 , 6 , 7 , 8 , 9 , …